Cubist Pharmaceuticals (CBST): Q4 EPS of $0.66 beats by $0.35. Revenue of $213M (+32% Y/Y) beats...

|By:, SA News Editor
Cubist Pharmaceuticals (CBST): Q4 EPS of $0.66 beats by $0.35. Revenue of $213M (+32% Y/Y) beats by $9M. Shares +0.5% AH. (PR)